📜 Origin
Triptorelin is a synthetic decapeptide belonging to the GnRH agonist class. It was developed by Nobel laureate Andrew V. Schally's team, who elucidated the structure of natural GnRH, by replacing the 6th glycine residue with D-tryptophan (D-Trp⁶). This modification aimed to overcome the inherent degradation and short half-life of natural hormones in the body. The compound was patented in 1975 and later developed by pharmaceutical companies such as Ipsen and Ferring into branded products like Decapeptyl and Trelstar. It was approved for clinical use in Europe in 1986.
🔬 Parameters
Amino acid sequence: pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH₂ (6th position is D-configuration tryptophan)
Molecular formula (free base): C₆₄H₈₂N₁₈O₁₃
Molecular weight (free base): Approx. 1311.5 Da
Acetate form (C₆₄H₈₂N₁₈O₁₃·C₂H₄O₂): MW approx. 1371.5 Da, CAS 160296-12-8 or 57773-63-4
Appearance: White or off-white lyophilized powder, hygroscopic, soluble in water and dilute acids/alkalis
Purity: Pharmacopoeia/Research grade (usually) ≥98% (HPLC)
Pharmacokinetics: Distribution half-life approximately several minutes to tens of minutes, terminal half-life approximately several hours; bioavailability nearly 100% after subcutaneous administration.
Common dosage forms: Daily micro-dose solution, 1-month, 3-month, and 6-month long-acting sustained-release implants/microspheres (e.g., Triptodur)
⚙️ Function
After triptorelin continuously binds to GnRH receptors in the anterior pituitary gland, it initially causes a transient increase in LH/FSH ("flare effect"), followed by receptor downregulation and desensitization, ultimately resulting in sustained inhibition of LH and FSH secretion. This strongly reduces the production of sex hormones (testosterone or estradiol) in the gonads (testes or ovaries), achieving a "drug castration" or deep inhibition of the gonadal axis.
✨ Advantages
High potency and selectivity: Significantly higher affinity for GnRH receptors than natural GnRH, and less prone to rapid enzymatic degradation, resulting in a longer-lasting effect.
High reversibility: Pituitary function usually recovers gradually after discontinuation of the drug, and the suppression of the gonadal axis is reversible (unlike surgical castration).
Diverse dosage forms and good compliance: From short-acting daily injections to long-acting depots of 3 months or even 6 months, it facilitates long-term management.
Broad indications: The same molecule can cover multiple hormone-dependent diseases through the concept of "continuous suppression of the gonadal axis."
🎯 Scenarios
Prostate cancer: Used for the treatment of advanced or specific stages of prostate cancer, by continuously suppressing testosterone to "starve" tumor cells.
Endometriosis/Uterine fibroids: Lowers estrogen levels, inhibits the growth of ectopic endometrium or shrinks fibroids, and relieves symptoms.
Central precocious puberty (CPP): Includes a 6-month long-acting formulation (Triptodur) for the management of central precocious puberty in children.
Assisted reproduction (IVF/ovulation induction): Used for pituitary downregulation, preventing early LH surges, and improving follicle synchronicity (commonly used in low-dose regimens for research).
Other Research/Special Uses: Some literature discusses its use in gender-affirming therapy, hormone management of certain sexual deviations, or related endocrine studies (professional/controlled settings).
⚠️ Precautions
Flare Effect: A transient increase in LH/FSH and sex hormones may occur in the initial stage of medication. Prostate cancer patients may experience increased bone pain and temporary worsening of urinary difficulties, often requiring a short-term anti-androgen (such as flutamide) transition.
Low Sex Hormone-Related Risks: Long-term suppression of the gonadal axis may be accompanied by hot flashes, decreased libido, breast tenderness, mood swings, osteoporosis/decreased bone density, etc.
Other Common Reactions: Injection site reactions, headache, fatigue, blood pressure fluctuations, and cyst formation (ovaries) have all been reported.
Allergic/Allergic-like Reactions: Although uncommon, caution is advised; preparations containing excipients (such as polysorbate) may also cause hypersensitivity.
Usage Restrictions: Mostly prescription/specially controlled drugs; research-grade raw materials are usually limited to laboratory research and cannot be directly equated with clinical use.
📁 Success Stories (Typical Directions and Value Demonstration)
Prostate Cancer Castration: In extensive clinical practice, long-acting triptorelin formulations are widely used as an alternative to surgical castration or in combination with total androgen blockade to achieve reversible testosterone suppression.
Precocious Puberty Management: The 6-month depot formulation (Triptodur) has been approved in the United States and other countries for central precocious puberty, extending dosing intervals and improving long-term adherence.
IVF Downregulation Optimization: Studies have shown that even extremely low daily doses (e.g., 15 µg) can achieve pituitary downregulation effects, providing data support for the refinement of assisted reproductive protocols.
Endometriosis Symptom Control: By maintaining a sustained low estrogen state, dysmenorrhea, pelvic pain, and lesion progression are alleviated, often serving as an option for preoperative lesion reduction or long-term management.
💎 Value
The core value of triptorelin lies in transforming the "natural GnRH signal" into a "controllable, continuous, and potent endocrine switch"-using continuous administration to stably suppress the pituitary-gonadal axis to the clinically required level, thereby providing an important, reversible, quantifiable, and well-established treatment tool in areas such as prostate cancer, endometriosis, precocious puberty, and assisted reproduction.
Hot Tags: China Triptorelin suppliers, China China Triptorelin suppliers manufacturers, suppliers, factory
